Aim to vaccinate 10 million people a day from August: Top govt adivsor

Arora also says there are plans to test mixing of vaccines in a few weeks to see if it helps in boosting immune response

Vaccination, coronavirus
Photo: Bloomberg
BS Web Team New Delhi
1 min read Last Updated : May 31 2021 | 3:37 PM IST
India is planning to vaccinate as many as 10 million people per day from August, the chief of coronavirus working group under National Technical Advisory Group on Immunization (NTAGI) said on Monday.

"By August we will have 200-250 million vaccine doses per month; another 50-60 million doses from other manufacturing units or if we get international vaccine doses," N K Arora was quoted as saying by ANI.

Arora also said that there are plans to start testing feasibility of a regimen in a few weeks that mixes 2 different doses of Covid vaccines to see if it helps boost immune response to virus.

In a boost to the sluggish vaccination drive, the government on Saturday said, nearly 120 million doses of Covid-19 vaccine would be available in June and around half of which would be supplied to states.

Serum Institute of India (SII), in a seperate letter, has informed the government that it will be able to manufacture and supply 9 to 10 million doses of Covishield shots in June.

India has administered more than 210 million doses so far, and of which, more than 10.8 million beneficiaries of age group 18-44 years were vaccinated in phase-3.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story